• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
GNCA

GNCA

Genocea Biosciences, Inc.

NASDAQHealthcareBiotechnologyUS

USD0.00

-0.00 (-85.71%)

Company Profile

CEO

William Clark

IPO Date

2014-02-05

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

Country

US

Market Metrics

Open

$0.00

Prev. Close

$0.00

Day Low

$0.00

Day High

$0.00

52W Low

$0.00

52W High

$1.45

Volume

0.03M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

18.1%

Avg Negative

3.9%

Avg Neutral

78.1%

News Feed

Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q2 2021 Results - Earnings Call Transcript

Seeking Alpha·7/29/2021·↓ negative

Genocea Provides Second Quarter 2021 Corporate Update

GlobeNewsWire·7/29/2021·↑ positive

Genocea to Host Second Quarter 2021 Corporate Update Conference Call & Webcast

GlobeNewsWire·7/22/2021·↑ positive

Genocea (GNCA) Begins Phase I/IIa Study for Solid Tumor Drug

Zacks Investment Research·7/14/2021·↑ positive

Genocea Doses First Patient in Phase 1/2a TiTAN Clinical Trial for GEN-011 Neoantigen-Targeted T cell Therapy

GlobeNewsWire·7/13/2021·↑ positive

Genocea Biosciences, Inc. (GNCA) CEO Chip Clark on Q1 2021 Results - Earnings Call Transcript

Seeking Alpha·4/29/2021·↓ negative

Genocea To Host First Quarter 2021 Corporate Update Conference Call & Webcast

GlobeNewsWire·4/22/2021·↑ positive

Genocea to Present Novel Preclinical Inhibigen™ Data at AACR Annual Meeting 2021

GlobeNewsWire·4/10/2021·↑ positive

Genocea to Present at the 20th Annual Needham Virtual Healthcare Conference

GlobeNewsWire·4/6/2021·↑ positive

Genocea Provides Fourth Quarter 2020 Corporate Update

GlobeNewsWire·2/11/2021·↑ positive